Olive Oil.

Cholecalciferol is absorbed only after it is packaged into bile salt micelles, and that packaging needs digestible long-chain fat. Olive oil in the same dose or meal supplies the lipid that carries it across.

Tocopherol uptake rises with the fat content of the meal, and olive oil provides it. In the other direction tocopherol sits in the oil and slows peroxidation of its unsaturated fatty acids during storage.

Retinyl esters are hydrolysed and then taken into micelles alongside dietary triglyceride. Olive oil supplies the fat phase that makes that step possible.

Carotenoids move from a food matrix into micelles only when fat is present, and the effect is steep at low fat intakes. Olive oil is a standard vehicle for that transfer.

Lutein needs a lipid phase to leave the plant matrix and enter mixed micelles. Adding olive oil to a lutein-containing meal raises how much reaches circulation.

Lycopene is highly non-polar and is poorly released from a low-fat matrix. Olive oil dissolves it and carries it into micelles, which is why tomato preparations are traditionally cooked in oil.

Astaxanthin is a lipid-soluble xanthophyll absorbed through micelles and chylomicrons. Dosing it with olive oil raises the fraction that gets across the intestinal wall.

Menaquinone-7 has a long isoprenoid tail and behaves like a dietary lipid in the gut. Olive oil supplies the fat needed for micellar uptake, and MK-7 softgels are commonly suspended in it for that reason.

Ubiquinone is a poorly soluble crystalline lipid whose uptake tracks with the fat it is dosed in. Suspending it in olive oil keeps it dissolved and supports micelle formation.

Hydroxytyrosol is one of the phenolic compounds naturally present in olive oil, largely as the free form released from oleuropein during processing. It accounts for much of the oil's resistance to oxidation.

Oleuropein is the parent secoiridoid glycoside in the olive fruit, and its hydrolysis yields hydroxytyrosol and elenolic acid in the oil. The two sit on the same biosynthetic line rather than acting independently.

Oleic acid makes up roughly three quarters of olive oil triglyceride and is what gives the oil its monounsaturated character. Most of the oil's effects on lipid handling run through this fatty acid.

Squalene is the main hydrocarbon in the unsaponifiable fraction of olive oil and a precursor in the sterol pathway. Its presence is one reason the oil resists oxidation during storage.

Phytosterols compete with cholesterol for micellar space only when they are themselves dissolved in the lipid phase. Delivering them in olive oil rather than as dry crystals keeps them in solution where that competition happens.

Curcumin is practically insoluble in water and its uptake improves when it is presented in a digestible oil that forms micelles. The pairing rests on solubility and formulation work rather than a settled dose-response in people.

Lecithin phospholipids lower interfacial tension and disperse an oil into fine droplets, increasing the surface available to pancreatic lipase. Pairing it with olive oil is standard practice in emulsions and softgel suspensions.

Vitamin K1 is absorbed only after it partitions into mixed micelles, and that step needs dietary fat and the bile release that fat triggers. A long-chain triglyceride oil such as olive oil supplies both. This is a delivery relationship, not an additive effect on any outcome.

Zeaxanthin is a fat-soluble pigment that has to dissolve in the lipid phase of a meal before it can cross the enterocyte. Olive oil provides that phase in a softgel fill or on a salad. Nothing here says the pair changes any clinical endpoint.

Tocotrienols travel the same micellar and chylomicron route as other vitamin E family members, so an oil vehicle matters for how much reaches circulation. Olive oil also contributes its own alpha-tocopherol to the mixture, which is worth accounting for when a label totals vitamin E. The two share a pathway rather than acting on each other.

Resveratrol dissolves poorly in water and is commonly suspended in an oil base for softgel filling. Olive oil is one of the oils used for that job. The pairing is about getting the molecule into solution, and the size of any absorption difference depends on the specific formulation.

Quercetin aglycone is close to insoluble in water, and lipid vehicles are a standard way to present it in a capsule. Olive oil serves as that vehicle in several softgel formats. Read this as formulation chemistry rather than a clinical interaction.

Pancreatic lipase cleaves the fatty acids off the glycerol backbone of olive oil triglycerides, and only the resulting free fatty acids and monoglycerides enter micelles. Where lipase output is low, the fat and anything dissolved in it move through less completely. The enzyme enables the oil, not the other way round.

Bile acids emulsify the oil into droplets small enough for lipase to work on, then carry the products in micelles to the brush border. Without adequate bile, a fat-soluble payload delivered in olive oil is absorbed less completely. This is textbook digestive physiology.

Blended digestive enzyme products contain lipase alongside protease and amylase, and the lipase fraction is the one that acts on an oil. Co-dosing is a formulation convention where fat digestion is the concern. It says nothing about any outcome beyond digestion of the fat itself.

Medium-chain triglycerides are absorbed largely via the portal vein without needing chylomicron packaging, while the long-chain oleic acid of olive oil goes through the lymphatic chylomicron route. Swapping one oil for the other in a softgel changes how a fat-soluble companion nutrient is carried. Neither route is preferable in general. They suit different jobs.

Oleic acid and linoleic acid compete for delta-6 desaturase and the downstream elongation steps, so the ratio of the two in a formula shifts which products dominate. Olive oil is oleic-acid dominant and shifts the balance away from a high-linoleic base such as corn or soybean oil. This is a substrate competition, not a claim about any health measure.

Long-chain omega-3s and olive oil triglycerides use the same lipase, micelle and chylomicron machinery, so they co-transport readily and are often blended in one softgel. Olive oil is also low in oxidisable polyunsaturated bonds, which is why it appears as a carrier around a more fragile oil. The pairing is about delivery and formulation stability.

DHA and olive oil have been given together in animal feeding work, where olive oil serves as the lipid matrix. Both are absorbed through the same micellar route. Animal co-dosing is not human evidence for an effect from the combination.

Rosemary extract, rich in carnosic acid, is a standard oil-soluble antioxidant added to fats to slow peroxide formation during storage. Olive oil already carries tocopherols and phenolics that do similar work. Together they are a shelf-stability pairing, and this is formulation practice rather than a physiological interaction.

Olive oil carries alpha-tocopherol, which quenches lipid radicals and is left as a tocopheroxyl radical. Water-phase ascorbate can hand an electron back and restore the tocopherol. The cycle is well described in chemistry. Whether it changes any measured outcome in a person is a separate question.

Phytosterols displace cholesterol from mixed micelles, and the same micelles are what carry other fat-soluble compounds delivered in an oil. Olive oil contributes its own sterol fraction to that pool. Where a formula stacks added sterols with fat-soluble vitamins, the competition for micellar capacity is worth noting.

Piperine is fat soluble and is usually presented in the lipid phase of a capsule alongside the active it accompanies. Olive oil is one of the fill oils used for that. The absorption work behind piperine concerns the partner molecule, not olive oil itself.

Garlic and olive oil have been combined in Mediterranean food practice for a very long time, and garlic-in-oil macerates carry over into supplement formats. Olive oil provides a lipid matrix for garlic's oil-soluble sulfur compounds. The basis is culinary and formulation convention, not a combination trial.